3Engelgau MM, Geiss LS, Saaddine JB, et al. The evolving diabetes burden in the United States [J]. Ann Intern Med, 2004, 140 : 945-950.
4Mann JI. Diet and risk of coronary heart disease and type 2 diabetes [J]. Lancet, 2002, 360: 783-789.
5Meydani SN, Han SN, Wu D.Vitamin E and immune response in the aged: molecular mechanisms an d clinical implications [J]. Immunol Rev2005, 205: 269-284.
6Rahman M J, Sarker P, Roy SK, et al.Efects of zinc supplementation as adjunct therapy on the systemic im une responses in shigellosis[J]. Am J CIin Nutr, 2005, 81: 495-502.
7Hosfeher TH.Mechanisms of diabetic nephropathy [J]. Am J Kidney Disease, 1994, 239 (2): 188-192.
8Rumsey SC, Daruwala R, Hasani H, et al. Dehydroascerbic acid transport by GLUT4 in xenopos cecytes and isolated rat adipocytes [J].J Biol Chem, 2000, 275 (36): 28246-28253.
9Funfstuck R,Nicolle LE,Hanefeld M,et al.Urinary tract infection in patients with diabetes mellitus[J].Clin Nephrol,2012;77( 1 ):40-48.
10Meydani SN,Han SN,Wu D.Vitamin E and immune response in the aged:molecular mechan isms an d clinical implications[J].lmmunol Rev,2005;205:269-284.
